RhumbLine Advisers
ICVX

RhumbLine Advisers’s Icosavax, Inc. Common Stock ICVX Stock Holding History

RhumbLine Advisers’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,538
Closed -$670K – 4291
2023
Q4 		$670K Buy
42,538
+1,767
+4% +$17K ﹤0.01% 2492
2023
Q3 		$316K Buy
40,771
+1,385
+4% +$11.5K ﹤0.01% 2905
2023
Q2 		$391K Buy
39,386
+4,746
+14% +$38K ﹤0.01% 2849
2023
Q1 		$201K Buy
34,640
+621
+2% +$5.37K ﹤0.01% 2739
2022
Q4 		$270K Buy
34,019
+1,414
+4% +$6.07K ﹤0.01% 2712
2022
Q3 		$103K Buy
32,605
+1,774
+6% +$11.1K ﹤0.01% 3000
2022
Q2 		$177K Buy
30,831
+10,469
+51% +$81.7K ﹤0.01% 2964
2022
Q1 		$143K Buy
20,362
+8,073
+66% +$127K ﹤0.01% 2830
2021
Q4 		$281K Buy
12,289
+264
+2% +$6.82K ﹤0.01% 2724
2021
Q3 		$356K Buy
+12,025
New +$408K ﹤0.01% 2695

RhumbLine Advisers's ICVX Position: Q1 2024 in Review

RhumbLine Advisers sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 42,538 shares — an estimated $670K sold.

RhumbLine Advisers first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $670K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • RhumbLine Advisers reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 42,538 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $670K.
  • RhumbLine Advisers first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • RhumbLine Advisers's Icosavax, Inc. Common Stock position peaked at $670K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.